Mary Holloway, President of DMH BioPharm Advisors, was included faculty at the Medical Affairs Professional Society’s (MAPs) Annual Meeting on June 21, 2017.  Mary spoke on “Understanding the FDA’s Draft Guidance on HCEI Communications with Payors, Formulary Committees, and Similar Entities.”   

Mary helped participants understand the changes in the 21st Center Cures Act and the recently released FDA draft guidance on Health Care Economic Information and how this affects their internal HCEI/payor strategy.  She also provided tips to ensure that MSLs and Access Teams deliver effective and compliant HCEI to customers.  The audience included Medical Affairs Leaders, Field Based Medical MSLs, and HEOR specialists.